filmov
tv
Eleni Efstathiou
1:28:41
AnCan presentation by Dr. Eleni Efstathiou - 12/19/2022
0:01:59
Eleni Efstathiou, MD, PhD, elaborates on the role of chemotherapy in mCRPC
0:02:18
Eleni Efstathiou, MD, PhD, discusses the prostate-specific membrane antigen (PSMA) lutetium
0:01:00
Eleni Efstathiou, MD, PhD, offers a message for patients on clinical progress in prostate cancer
0:02:58
Eleni Efstathiou, MD, PhD, offers opinion on the ACIS clinical trial
0:02:27
Eleni Efstathiou, MD, PhD, considers the role of precision medicine in prostate cancer
0:02:03
Eleni Efstathiou, MD, PhD, on whether genetic mutation data impacts the treatment of prostate cancer
0:02:02
Eleni Efstathiou, MD, PhD, discusses the CheckMate 9ER clinical trial presented at ESMO 2020
0:01:11
Eleni Efstathiou, MD, PhD, provides perspective on the IPATential150 study in mCRPC
0:02:21
Eleni Efstathiou, MD, PhD, on the practice-changing potential of the PROfound study from ESMO 2020
0:01:49
Eleni Efstathiou, MD, PhD, regarding the preliminary analysis of belzutifan & cabozantinib in ccRCC
0:02:44
Eleni Efstathiou, MD, PhD, regarding the PROSPER clinical trial from ASCO GU 2021
0:01:34
Eleni Efstathiou, MD, PhD, shares thoughts on the TROPHY-U-01 clinical study presented at ESMO 2020
0:01:33
Eleni Efstathiou, MD, PhD, offers opinion on whether CheckMate 9ER is practice-changing
0:00:57
Eleni Efstathiou, MD, PhD, regarding patients more likely to respond to nivolumab + cabozantinib
0:01:18
Making advances in prostate cancer
0:01:33
Biomarkers for the management of prostate cancer
0:13:39
GU Debates 2019: Updates on genitourinary cancers (2/2)
0:02:16
Personalizing Prostate Cancer Treatment | Houston Methodist
0:00:16
October 22, 2024
0:02:31
Abiraterone: a step forward in the treatment of prostate cancer
0:10:25
ASCO GU 2022 - Janssen Highlights Niraparib Combo Data
0:28:42
EAU guidelines for treating patients with advanced prostate cancer
0:01:30
Introducing biomarkers for the management of patients with prostate cancer
Вперёд
welcome to shbcf.ru